Clinical analysis of the ACOSOG Z0011 trial applied to young breast cancer
Medical Journal of Chinese People′s Liberation ArmyVol. 49, Issue 12, Pages: 1394-1399(2024)
Clinical Research|更新时间:2025-01-08
|
分享给微信好友或者朋友圈
导出参考文献
Clinical analysis of the ACOSOG Z0011 trial applied to young breast cancer
“According to the research of the Second Affiliated Hospital of Nanchang University, young breast cancer patients are exempted from axillary lymph node dissection according to the ACOSOG Z0011 test standard, and the local recurrence rate is high, but it does not affect the overall survival period.”
Xia Kun-Jian,Wang Lin,Tang Na.Clinical analysis of the ACOSOG Z0011 trial applied to young breast cancer[J].Medical Journal of Chinese People′s Liberation Army,2024,49(12):1394-1399.
Xia Kun-Jian,Wang Lin,Tang Na.Clinical analysis of the ACOSOG Z0011 trial applied to young breast cancer[J].Medical Journal of Chinese People′s Liberation Army,2024,49(12):1394-1399. DOI: 10.11855/j.issn.0577-7402.1155.2024.0418.
Clinical analysis of the ACOSOG Z0011 trial applied to young breast cancer